Teva Pharmaceutical Industries Limited · Health Care
Teva Pharmaceutical is a global generic and specialty pharmaceutical powerhouse leading in complex formulations and biosimilars. The stock is currently powered by its 'Pivot to Growth' strategy, driven by AUSTEDO and AJOVY commercial strength alongside pipeline progress with anti-TL1A therapy.
The AlphaInsight Score is a proprietary 0–100 composite of momentum, valuation, growth and safety factors. Research snapshot updated 2026-09-05.
AUSTEDO continues to capture substantial share in tardive dyskinesia and chorea, tracking toward multi-billion-dollar peak sales. Duvakitug (anti-TL1A partnered with Sanofi) offers substantial upside in inflammatory bowel disease, representing a major novel pipeline driver. Debt loads have decreased markedly, unlocking multiple expansion as litigation overhangs recede.
Commodity generic markets in the US and Europe remain vulnerable to periodic pricing headwinds and manufacturing compliance hurdles. Substantial outstanding debt obligations still constrain aggressive shareholder return initiatives relative to peers. Looming competition in migraine and movement disorders could moderate specialty franchise growth.
Teva Pharmaceutical Industries Limited scores 84/100 on the AlphaInsight Score — ranked #29 of 656 stocks in our research universe. It blends momentum (86/100), valuation (78/100), growth (74/100) and safety (70/100).
TEVA currently carries an AlphaInsight Score of 84/100 in our research system. Subscribers receive daily entry, target and stop-loss levels whenever it appears in a slate.
Commodity generic markets in the US and Europe remain vulnerable to periodic pricing headwinds and manufacturing compliance hurdles. Substantial outstanding debt obligations still constrain aggressive shareholder return initiatives relative to peers. Looming competition in migraine and movement disorders could moderate specialty franchise growth.
Compare TEVA head-to-head with VTRS, OGN, NBIX on AlphaInsight Scores, valuation, growth and safety factors.
Subscribers get the complete thesis, risk factors and technical breakdown for TEVAand 10 researched ideas every trading day.
Cancel anytime · Secure checkout
Ready-to-paste citation snippets for forums, Reddit, X or your own site.
[TEVA stock research — AlphaInsight Score & technical signals](https://alphainsightai.net/stocks/TEVA)<a href="https://alphainsightai.net/stocks/TEVA">TEVA stock research — AlphaInsight Score & technical signals</a>